Scopolamine Patch, Extended Release
Product Images NDC 72162-2453

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Scopolamine (NDC 72162-2453). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Extended Label (Lbl713352453extendedlabel)

Text panel titled 'Dosage and Administration' providing step-by-step instructions for the use of a transdermal system. Instructions include washing and drying hands before application, using one patch at a time without cutting, removing the plastic backing, applying behind the ear, and washing hands after application.*

FDA Label Image

Label (Lbl721622453)

Label for Scopolamine Transdermal System 1 mg/3 days patch, an extended release transdermal drug. The label shows the product strength, manufacturer Bryant Ranch Prepack, and relabeler information. It includes packaging instructions such as storage temperature and caution about use during MRI procedures. The package contains 4 transdermal systems in a multipack format.*

FDA Label Image

Chemical Structure (Scopolamine 01)

Chemical structure of scopolamine, showing its molecular arrangement including a tropane ring, an epoxide bridge, and a benzoyl group with hydroxyl substitution.*

FDA Label Image

Image (Scopolamine 02)

An illustration depicting the layered structure of a Scopolamine transdermal patch. The layers shown are, from top to bottom: Backing Membrane, Drug Layer, Rate Controlling Membrane, Contact Layer, and Release Liner.*

FDA Label Image

Figure 1 (Scopolamine 03)

An instructional diagram showing the components of a Scopolamine extended-release patch. It highlights the clear disposable release liner, metallic adhesive surface, and tan backing membrane with the imprint 'Scopolamine 1mg/3 days.'*

FDA Label Image

Figure 2 (Scopolamine 04)

An instructional diagram showing a sheet of paper with a dotted line near the top and the instruction to "cut along dotted line." The figure is labeled as "Figure 2." The image appears to be part of usage or preparation instructions.*

FDA Label Image

Figure 3 (Scopolamine 05)

Illustration showing two hands holding a scopolamine transdermal patch by its edges, demonstrating the removal of the protective liner from the patch. The background features a stylized wing design. Labeled as Figure 3.*

FDA Label Image

Figure 4 (Scopolamine 06)

An instructional illustration showing two fingers peeling the clear, disposable release liner from the back of an imprinted, tan-colored scopolamine transdermal patch with a metallic adhesive surface.*

FDA Label Image

Figure 5 (Scopolamine 07)

An illustration showing the proper placement of a scopolamine transdermal patch behind the ear on the side of the head. The patch is described as imprinted and tan-colored.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.